Another Study Identifies Actos Bladder Cancer Side Effects

Side effects linking the diabetes drug Actos to bladder cancer have been identified by yet another study.

Researchers published study results on July 3 in the Canadian Medical Association Journal, confirming an association between bladder cancer and Actos.  This is the latest in a growing number of studies establishing a link between the popular drug and potentially fatal cancer.

In this most recent study, researchers reviewed a number of biomedical databases, studies, and trials including information on 2,657,365 patients.  Of the patients studied, 3,643 had a bladder cancer diagnosis.

Study leaders found a 22% higher rate of bladder cancer in patients with type 2 diabetes using Actos or other drugs that belong to the same class of medications, including Avandia and Rezulin.

This latest research follows two other studies confirming the link between Actos and bladder cancer.  In one study, by the University of Pennsylvania, the increased risk of patients taking this class of drugs was found to be closer to 74%.  In a recent Canadian study, the link was only attributed to Actos.

Since September 2010, the FDA has been monitoring the potential link between Actos and bladder cancer.  In 2011, a French insurance study was the first to positively report an association between the drug and cancer.  This study led to an Actos recall in France and Germany.  The European Union and the United States opted to keep the drug on the market, but to increase warning labels on Actos to reflect this link.

Actos (pioglitazone) was released by Takeda Pharmaceuticals and approved by the FDA to treat type 2 diabetes in July 1999.  Similar medications used to increase insulin sensitivity include ActoPlus Met and Duetact.

Contact an Actos Lawyer

Dangerous drug lawsuits are being pursued by a growing number of Actos patients who have been diagnosed with bladder cancer.  If you have type 2 diabetes and have been diagnosed with bladder cancer, your medication may be responsible.  To learn more about this link and your possible right to substantial compensation, contact a pharmaceutical product liability lawyer for a free legal consultation.

July 18, 2012 | Tags: Actos, Dangerous Drugs

View All Legal News